Psoriasis and chronic obstructive pulmonary disease: A case-control study

British Journal of Dermatology

Volumn 159, Issue 4, 2008, Pages 956-960

  Dreiher, J ^a,b   Weitzman, D ^b   Shapiro, J ^c   Davidovici, B ^d   Cohen, A D ^a,b  

^a CLALIT HEALTH SERVICES   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease; Comorbidity; Obstructive lung disease; Psoriasis

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SMOKING HABIT; SOCIOECONOMICS;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; PSORIASIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 51849111494     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08749.x     Document Type: Article

References (28)

1. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005 64 (Suppl. 2 ii18 23.
2. Schön M, Boehncke WH. Psoriasis. N Engl J Med 2005 352 : 1899 912.
3. Schafer T. Epidemiology of psoriasis: review and the German perspective. Dermatology 2006 212 : 327 37.
4. Pietrzak A, Lecewicz-Torun B. Activity of serum lipase (EC 3.1.1.3) and the diversity of serum lipid profile in psoriasis. Med Sci Monit 2002 8 : CR9 13.
5. Pearce DJ, Morrison AE, Higgins KB et al. The comorbid state of psoriasis in a university dermatology practice. J Dermatolog Treat 2005 16 : 319 23.
6. Wakkee M, Thio HB, Prens EP et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007 190 : 1 9.
7. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006 296 : 1735 41.
8. Mallbris L, Granath F, Hamsten A, Ståhle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006 54 : 614 21.
9. Naldi L, Chatenoud L, Linder D et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005 125 : 61 7.
10. Neimann AL, Shin DB, Wang X et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 35.
11. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006 298 : 321 8.
12. Sterry W, Strober BE, Menter A, on behalf of the International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007 157 : 649 55.
13. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of COPD: GOLD executive summary. Am J Respir Crit Care Med 2007 176 : 532 55.
14. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008 31 : 204 12.
15. Soriano JB, Visick GT, Muellerova H et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005 128 : 2099 107.
16. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax 2003 58 : 832 4.
17. Anreakos E. Common and uncommon features of rheumatoid arthritis and chronic obstructive pulmonary disease: clues to a future therapy. Curr Drug Targets Immune Endocr Metabol Disord 2004 4 : 85 92.
18. Marquis K, Maltais F, Duguay V et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005 25 : 226 32.
19. Rana JS, Mittelman MA, Sheiki J et al. Chronic obstructive pulmonary disease and risk of type 2 diabetes in women. Diabetes Care 2004 27 : 2478 84.
20. Cohen AD, Shapiro Y, Davidovici B et al. Psoriasis and ischemic heart disease: a case-control study. G Ital Dermatol Venereol 2007 142 : 299 302.
21. Shapiro J, Cohen AD, David M et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007 56 : 629 34.
22. Cohen AD, Dreiher J, Shapiro Y et al. Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol 2008 22 : 585 9.
23. Cohen AD, Gilutz H, Henkin Y et al. Psoriasis and the metabolic syndrome. Acta Derm Venereol (Stockh) 2007 87 : 506 9.
24. Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 2001 3 : 404 8.
25. Vinker S, Fogelman Y, Elhayany A et al. Usefulness of electronic databases for the detection of unrecognized diabetes patients. Cardiovasc Diabetol 2003 2 : 13.
26. Farshichian M, Zamanian A, Farshichian M et al. Serum lipid levels in Iranian patients with psoriasis. J Eur Acad Dermatol Venereol 2007 21 : 802 5.
27. Vanizor Kural B, Orem A, Cimsit G et al. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationship with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta 2003 328 : 71 82.
28. Ministry of Health. Minister of Health's Report on Smoking in Israel 2006-2007, May 2007 (Hebrew). Available at http://www.health.gov.il/download/ pages/Nosmoke2007.pdf (last accessed 22 January 2008).